GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Fredun Pharmaceuticals Ltd
Fredun Pharmaceuticals Sets Record Date for FY26 Final Dividend
DIVIDEND ▲ Positive Development LOW RISK
📅 Filed on BSE: 08 Jun 2026, 07:36 PM IST  ·  BSE ID: f7228fc1-509c-42a7-8042-b5079b439cc6
View Original BSE Filing (PDF)
💡
In Simple Terms
The company has picked a specific date for shareholders to be eligible for its proposed final dividend.
🤖 AI Summary
  • Fredun Pharmaceuticals sets June 23, 2026, as the record date for final dividend.
  • Final dividend declared is 7% on equity shares for FY 2025-26.
  • Payment of dividend is subject to shareholder approval at the ensuing AGM.
  • Dividend payment will be processed within 30 days of AGM approval.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Record Date
23rd June, 2026
Final Dividend
7%
Face Value per Equity Share
Rs. 10/-
Financial Year
2025-26
🏢 How This Affects the Company
💰
Financial Impact
The declaration of a final dividend will result in a cash outflow from the company to its shareholders upon approval.
⚠️
Risk Impact
Failure to pay the dividend within the stipulated timeframe post-AGM approval could lead to regulatory scrutiny.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this stage. Shareholders must hold shares on the record date to be eligible.
👤
Who Is Affected
All registered shareholders of Fredun Pharmaceuticals as of June 23, 2026, will be entitled to the final dividend.
🔍
Management Signal
Management intends to reward shareholders with a dividend, indicating confidence in past financial performance and future cash flows.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Annual General Meeting date for dividend approval.
AGM outcome regarding dividend approval status.
Confirmation of dividend payment initiation post-AGM.
LOW RISK Routine corporate action related to dividend distribution; low inherent risk.
💡 Investor Takeaway
Fredun Pharmaceuticals confirmed June 23, 2026, as the record date for its 7% final dividend on equity shares for FY 2025-26, payable post-AGM approval.
❓ Frequently Asked Questions
What is Fredun Pharmaceuticals' record date for the final dividend?
Fredun Pharmaceuticals has set Tuesday, 23rd June, 2026, as the record date for its final dividend.
What is the percentage of the final dividend for FY 2025-26?
The final dividend declared is 7% on equity shares, with a face value of Rs. 10/- each.
When will the final dividend be paid by Fredun Pharmaceuticals?
Payment of the final dividend will be made within 30 days from the date of approval by shareholders at the ensuing Annual General Meeting.
Who is eligible for the final dividend?
Shareholders whose names appear on the company's register of members on the record date, June 23, 2026, are eligible for the dividend.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.